Click the link below to access the glossary.
- First Treatment for MPS IVA Approved
- Annual EveryLife Art Contest
- BioMarin Announces FDA Approval for VIMIZIM(TM) (elosulfase alfa) for the Treatment of Patients With Morquio A Syndrome
- BioMarin Announces Selection of NAGLU, BMN 250 for the Treatment of Sanfilippo B